BiBBInstruments AB releases good news

This week, BiBBInstruments AB released news that the first commercial order for EndoDrill® GI has been received from the US market. At an investor presentation in Denmark, CEO Fredrik Lindblad later revealed that also a second order has been received. Although modest in financial impact, these orders mark an important milestone for BiBBInstruments AB on its path towards proving the huge potential for EndoDrill® GI on the US market.

In September, BiBBInstruments AB announced that Professor Peter Vilmann has agreed to serve as a Scientific Advisor for the company. At LSIF, we see this as a major achievement as Professor Peter Vilmann is a world-renowned KOL and pioneer in this field. He was the first in the world to perform EUS-guided fine needle biopsy (FNA) in 1991, and he is co-inventor of the first needle assembly for EUS-guided aspiration biopsy. That Professor Vilmann now endorses and sees EndoDrill® GI as a potential game changer holds great promise for BiBBInstruments AB in our view.

We look forward to follow the launch and to see tracktion building up in the US as well as seeing a launch in Europe in 2026.